QR код

Colonic Tissue Expression of MAdCAM‐1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel Disease

ABSTRACT We assessed the predictive value of MAdCAM‐1 expression on response to vedolizumab in patients with inflammatory bowel disease. This was a retrospective, single‐center, cohort study including 109 patients with pretreatment inflammation who completed at least three doses of vedolizumab. We d...

Повний опис

Збережено в:
Автори: Nikhil Reddy, Jeremy A. Klein, Nikita Thomas, Dejan Micic, Zifeng Deng, David T. Rubin, Russell D. Cohen, Sushila Dalal, Britt Christensen, Haider I. Haider, Vesta Valuckaite, Katherine R. Meckel, Marc Bissonnette, Christopher R. Weber, Joel Pekow
Формат: Artigo
Мова:Inglês
Опубліковано: Wiley 2025-12-01
Серія:Clinical and Translational Science
Предмети:
immunology
inflammation
molecular therapeutics
monoclonal antibodies
pharmacology
therapeuticsgastrointestinal
Онлайн доступ:https://doi.org/10.1111/cts.70422
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси